Genomic determinants of motor and cognitive outcomes in Parkinson's disease
- PMID: 22658654
- PMCID: PMC3606821
- DOI: 10.1016/j.parkreldis.2012.04.025
Genomic determinants of motor and cognitive outcomes in Parkinson's disease
Abstract
Background: Little is known regarding genetic factors associated with motor or cognitive outcomes in Parkinson's disease (PD).
Objective: To identify common genetic variants associated with motor and cognitive outcomes in PD.
Methods: The sample consisted of 443 PD cases included in the first genome-wide association study (GWAS) of PD. Methods included telephone interview assessments of motor and cognitive outcomes, a median 9 years following the initial clinical assessments. Analyses included Cox proportional hazard models to study the association of 198,345 single nucleotide polymorphisms (SNPs) with survival free of Hoehn and Yahr stage ≥ 4 (motor outcome), and either TICS-M ≤ 27 or AD-8 ≥ 2 (cognitive outcomes).
Results: The SNP rs10958605 in the C8orf4 gene had the smallest p value in analyses of the motor outcome (HR = 1.81; 95% CI = 1.42-2.31; p = 1.51 × 10(-6)). The SNP rs6482992 in the CLRN3 gene had the smallest p value in analyses of the cognitive outcome (HR = 2.03, 95% CI 1.47-2.79, p = 4.08 × 10(-6)). However, no SNP associations were significant after Bonferroni correction. The C8orf4 gene had small p values for both motor and cognitive outcomes, highlighting inflammation as a possible pathogenesis mechanism for progression in PD.
Conclusions: This study suggests that common variants in several genes may be associated with motor and cognitive outcomes in PD, with biological plausibility.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures


Similar articles
-
Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.JAMA Neurol. 2018 Mar 1;75(3):360-366. doi: 10.1001/jamaneurol.2017.4206. JAMA Neurol. 2018. PMID: 29340614 Free PMC article.
-
Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.Parkinsonism Relat Disord. 2016 Mar;24:89-94. doi: 10.1016/j.parkreldis.2015.12.018. Epub 2015 Dec 30. Parkinsonism Relat Disord. 2016. PMID: 26776090
-
Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.Neurobiol Aging. 2013 Nov;34(11):2695.e1-7. doi: 10.1016/j.neurobiolaging.2013.05.022. Epub 2013 Jun 29. Neurobiol Aging. 2013. PMID: 23820587
-
Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.Neurobiol Aging. 2014 Jun;35(6):1512.e5-1512.e10. doi: 10.1016/j.neurobiolaging.2013.12.020. Epub 2013 Dec 27. Neurobiol Aging. 2014. PMID: 24439955 Free PMC article.
-
A cumulative genetic risk score predicts progression in Parkinson's disease.Mov Disord. 2016 Apr;31(4):487-90. doi: 10.1002/mds.26505. Epub 2016 Feb 8. Mov Disord. 2016. PMID: 26853697 Review.
Cited by
-
Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.J Genet. 2018 Jul;97(3):625-648. J Genet. 2018. PMID: 30027900 Review.
-
The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach.Front Aging Neurosci. 2022 Jun 27;14:866886. doi: 10.3389/fnagi.2022.866886. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35832065 Free PMC article.
-
SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.Biomed Res Int. 2015;2015:135674. doi: 10.1155/2015/135674. Epub 2015 Apr 15. Biomed Res Int. 2015. PMID: 25960998 Free PMC article.
-
Regulatory and sequence evolution in response to selection for improved associative learning ability in Nasonia vitripennis.BMC Genomics. 2018 Dec 10;19(1):892. doi: 10.1186/s12864-018-5310-9. BMC Genomics. 2018. PMID: 30526508 Free PMC article.
-
Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?Parkinsonism Relat Disord. 2014 Jun;20(6):584-9; discussion 584. doi: 10.1016/j.parkreldis.2014.02.021. Epub 2014 Mar 5. Parkinsonism Relat Disord. 2014. PMID: 24656894 Free PMC article.
References
-
- Elbaz A, Bower JH, Peterson BJ, Maraganore DM, McDonnell SK, Ahlskog JE, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol. 2003;60:91–96. - PubMed
-
- Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology. 2005;65:1436–1441. - PubMed
-
- Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70:1017–1022. - PubMed
-
- Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20:190–199. - PubMed
-
- Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23:837–844. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases